Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark D. Reeth currently holds 33,668 shares of SALIX PHARMACEUTICALS LTD (SLXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark D. Reeth has been a net seller of SLXP stock. They have purchased $0 and sold $852.8K worth of shares.
Mark D. Reeth's most recent insider trade was on May 1, 2012, when they sold 1,000 shares at $48.91 per share.
Mark D. Reeth serves as Executive at SALIX PHARMACEUTICALS LTD (SLXP). They have executed 19 insider transactions totaling $852.8K over their tenure at the company.
Mark D. Reeth holds the position of Executive at SALIX PHARMACEUTICALS LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark D. Reeth has shown a selling trading pattern, with $0 in total purchases and $852.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark D. Reeth was on Jul 5, 2011, when they sold $296.6K worth of SLXP shares. This transaction involved 7,357 shares at $40.32 per share.
Mark D. Reeth currently owns 33,668 shares of SALIX PHARMACEUTICALS LTD (SLXP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark D. Reeth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark D. Reeth has 19 Form 4 filings on record as an insider at SALIX PHARMACEUTICALS LTD.
Set alerts for Mark D. Reeth and 40,000+ other insiders.